市場調查報告書
商品編碼
1376883
反流測試設備市場規模 - 按產品類型(反流膠囊、反流探頭、反流導管)、按應用、按最終用途 - 2022-2032 年全球預測Reflux Testing Devices Market Size - By Product Type (Reflux Capsule, Reflux Probe, Reflux Catheter), By Application, By End-use - Global Forecast 2022-2032 |
在人口快速老化和不健康生活習慣湧入的推動下,2023年至2032年,逆流測試設備市場規模將以4.7%的年複合成長率成長。胃食道逆流症 (GERD) 和其他胃腸道疾病的盛行率不斷上升,增加了對診斷工具的需求。人們對 GERD 相關併發症和早期診斷重要性的認知不斷增強,也促使患者尋求各種檢測方法。
反流測試設備的技術進步,包括無線和更適合患者的選項,以提高可及性和患者舒適度,也將推動行業的成長。例如,2023 年 4 月,Laborie Medical Technologies Corp. 推出了 alpHaONE 系統來治療 GERD,並提供長達 96 小時的監測資料,以幫助改善患者治療結果並增強整體體驗。
反流測試設備市場根據產品類型、應用、最終用途和地區進行分類。
根據產品類型,回流導管細分市場的市場規模將在 2032 年之前體現出顯著的年複合成長率,因為它們能夠提供準確和即時的資料。對微創診斷工具不斷成長的需求也將推動產品的採用。
在抗逆流手術和內視鏡手術數量不斷增加的推動下,外科手術應用領域的逆流測試設備產業佔有率將在 2023 年至 2032 年期間呈現顯著成長。人們越來越認知到準確的術前診斷的重要性以及微創手術技術的進步也將推動外科手術中的產品需求。
就最終用途而言,預計到 2032 年,門診手術中心領域將累積可觀的市場佔有率。這一成長是由門診手術的日益轉變和門診手術中心的成本效益所推動的。簡化患者護理的便利性以及對高效能、當日診斷和治療的日益偏好也將有利於該細分市場的成長。
從地區來看,在胃腸道疾病發病率上升的推動下,亞太地區反流測試設備產業預計在 2023 年至 2032 年期間將以強勁的速度成長。人們對反流相關問題的認知不斷提高,為該地區醫療基礎設施的持續建設讓路。此外,先進診斷技術的更多採用將促進區域產業擴張。
Reflux testing devices market size will grow at 4.7% CAGR from 2023 to 2032 driven by the rapidly aging population and influx of unhealthy lifestyle habits. The rising prevalence of gastroesophageal reflux diseases (GERD) and other gastrointestinal disorders is increasing the demand for diagnostic tools. The growing awareness of GERD-related complications and the importance of early diagnosis is also driving patients to seek various testing methods.
The technological advancements in reflux testing devices, including wireless and more patient-friendly options to enhance accessibility and patient comfort will also fuel the industry growth. For instance, in April 2023, Laborie Medical Technologies Corp. introduced the alpHaONE system to treat GERDs and offer up to 96 hours of monitoring data to help in improving patient outcomes and enhance overall experience.
The reflux testing devices market is segregated based on product type, application, end-use, and region.
Based on product type, the market size from the reflux catheter segment will reflect significant CAGR through 2032 due to their ability to provide accurate and real-time data. The increasing demand for minimally invasive diagnostic tools will also drive the product adoption.
Reflux testing devices industry share from the surgical procedure application segment will exhibit appreciable growth during 2023-2032, driven by the rising number of anti-reflux surgeries and endoscopic procedures. The increasing awareness of the importance of accurate preoperative diagnostics along with the advancements in minimally invasive surgical techniques will also push the product demand in surgical procedures.
In terms of end-use, the ambulatory surgical centers segment is projected to accumulate commendable market share by 2032. The growth is driven by the rising shift toward outpatient procedures and cost-effectiveness in ambulatory surgical centers. The ease of access to streamlined patient care along with the growing preference for efficient, same-day diagnosis and treatment will also favor the segment growth.
Regionally, the Asia Pacific reflux testing devices industry is estimated to grow at a robust rate from 2023 to 2032, driven by the rising incidences of gastrointestinal disorders. The increasing awareness of reflux-related issues is making way for the rising healthcare infrastructure in the region. Furthermore, the higher adoption of advanced diagnostic technologies will bolster the regional industry expansion.